COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans

被引:67
作者
Wang, J
Morimitsu, Y
Okamoto, S
Hisaoka, M
Ishida, T
Sheng, WQ
Hashimoto, H
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Oncol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
[2] Tokyo Univ Hosp, Fac Med, Dept Pathol, Tokyo 113, Japan
[3] Shanghai Med Univ, Canc Hosp, Dept Pathol, Shanghai 200032, Peoples R China
关键词
D O I
10.1016/S1525-1578(10)60614-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The fibrosarcomatous transformation of dermatofibrosarcoma protuberans (DFSP) has been considered for some time to be associated with an adverse clinical outcome. However, the molecular and cellular mechanism underlying the tumor progression remains undetermined. As the chimeric gene, COL1A1-PDGFB, has been proposed to play an important role in the histogenesis of DFSP, we conducted a reverse transcription-polymerase chain reaction assay to ascertain whether the COL1A1-PDGFB fusion transcripts can be detected in both conventional DFSP and fibrosarcomatous components of DFSP with fibrosarcomatous areas (DFSP-FS), using a simple method of microdissection on sections of archival formalin-fixed, paraffin-embedded tumor specimens from six DFSP-FS cases. The COL1A1-PDGFB fusion transcripts could be detected in FS areas in five of the six cases, whereas conventional DFSP areas of all cases expressed the chimeric mRNA. A subsequent sequence analysis of the polymerase chain reaction products confirmed that the detected messages were derived from identical gene fusions in the two different components of each of the five cases. Our results verify that the COL1A1-PDGFB fusion transcripts are preserved in the FS areas of most DFSP-FSs. The expression of the fusion transcripts in both conventional DFSP and FS areas of DFSP-FS supports a common histogenesis of the two components.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 43 条
[1]  
Argani P, 1998, MODERN PATHOL, V11, P65
[2]   ANTIGRANULOCYTES CELL VARIANT OF DERMATOFIBROSARCOMA PROTUBERANS [J].
BANERJEE, SS ;
HARRIS, M ;
EYDEN, BP ;
HAMID, BNA .
HISTOPATHOLOGY, 1990, 17 (04) :375-378
[3]   DERMATOFIBROSARCOMA PROTUBERANS WITH AREAS RESEMBLING GIANT-CELL FIBROBLASTOMA - REPORT OF 2 CASES [J].
BEHAM, A ;
FLETCHER, CDM .
HISTOPATHOLOGY, 1990, 17 (02) :165-167
[4]   Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: Clinicopathologic analysis of 5 cases [J].
Calonje, E ;
Fletcher, CDM .
JOURNAL OF CUTANEOUS PATHOLOGY, 1996, 23 (01) :30-36
[5]   DERMATOFIBROSARCOMA PROTUBERANS - A CLINICOPATHOLOGICAL REVIEW WITH EMPHASIS ON FIBROSARCOMATOUS AREAS [J].
CONNELLY, JH ;
EVANS, HL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (10) :921-925
[6]   Atrophic and plaquelike dermatofibrosarcoma protuberans [J].
Davis, DA ;
Sanchez, RL .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1998, 20 (05) :498-501
[7]  
DeiTos AP, 1997, VIRCHOWS ARCH, V431, P83
[8]   Dermatofibrosarcoma protuberans with fibrosarcomatous areas: A clinico-pathologic and immunohistochemic study in four cases [J].
DiazCascajo, C ;
Weyers, W ;
Borrego, L ;
Inarrea, JB ;
Borghi, S .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1997, 19 (06) :562-567
[9]  
DING J, 1989, CANCER, V64, P721, DOI 10.1002/1097-0142(19890801)64:3<721::AID-CNCR2820640326>3.0.CO
[10]  
2-Q